Identity
- Security key
- 17885
- Ticker
- KYNB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2014-11-14
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- KYNB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $28,741,595.2
- Shares outstanding (class)
- 4,048,112
- Shares outstanding (weighted)
- 4,048,112
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 34
- Location
- SAN FRANCISCO, CA
- Homepage
- https://www.kyntrabio.com
- Description
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.